Interview with Richard de Chastelain, Country Division Head, Bayer Healthcare South Africa
10.08.2012
Related Interviews
African Medicines Agency / Progress, Roadblocks & Momentum
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Interview: Andre Buhrlen – Managing Director, Hersol Manufacturing…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Interview: Albert Denoon – Owner, Baroque Medical, – Board Member,…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
Vietnam / Opportunities Abound in $6.5bn Pharma Market
As geopolitical tensions between China and the US increase and pharma industry stakeholders are increasingly looking elsewhere in Asia to diversify their supply chains, Vietnam has emerged as a highly…
Opinion / Health at the UN General Assembly: Innovation & Equity for Pandemic Preparedness
Ahead of the 78th session of the United Nations General Assembly (UNGA78), IFPMA Director General Thomas Cueni underscores the need for pandemic preparedness plans to support innovation and equity. Global…
Morocco / Recipharm’s Bet on Africa's Vaccine Independence
The COVID-19 pandemic exposed Africa’s dependence on overseas production as vaccines were quickly rolled out in other parts of the world while African countries remained at the bottom of the…
